Future studies should determine the mechanisms by which palliative chemotherapy is associated with increased risk of receiving intensive care at the end of life and dying in an intensive care unit and examine explicitly whether palliative chemotherapy is associated with patients' goal attainment.
Decades ago, on the day before my finals were to begin at university in England — the five days of intensive exams at the end of our final year that would determine our degrees, our futures and, so it seemed, our lives — I happened to run into my tutor, the cool, white-shoed poet who had been responsible for my academic welfare for all three years.
If England were like a patient in intensive care at the end of the Ashes series in Australia, on Thursday the sick man made his first tentative steps on the road to recovery.
The cortex is undergoing growth and intensive development at the end of gestation, as well as after birth and in youth.
Patients with chronic disease require increased care, which may include intensive care, at the end of life (EOL) [ 3], defined as the last 6 months before death.
Furthermore, no state-wide population-based studies have described emergency department (ED) presentations or time spent in intensive care at the end of life in NSW.
Measures of pain, function, and functional health status were obtained at baseline, after 5 weeks of intensive training, at the end of the 57-week rehabilitation programme, and at a 1 year follow-up, using validated self-administrated measures.
In Poland there is a statement in the Code of Medical Ethics that obliges doctors to care for patients with incurable diseases and that offers patients the possibility to resign from intensive care at the end stage of incurable diseases.
Our results suggest that terminally ill patients with advanced cancers who receive chemotherapy a few months before death are more likely to receive intensive care at the end of life, compared with patients who do not.
61 Also, the excess deaths from any cause (primarily cardiovascular), observed in the intensive arm at the end of the intervention for 3.7 years, persisted after a follow-up period of 1.3 years, in spite of similar HbA1c levels, use of glucose-lowering medications, and rates of severe hypoglycemia in the intensive and standard intervention groups.
